CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at $3.16 ($47,343)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Operating Officer bought 20,000 shares at an average $1.79 ($35,820)
- 4 Open-market buy Chief Financial Officer bought 13,000 shares at an average $1.68 ($21,839)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 25,000 shares at an average $2.77 ($69,129)
- 4 Grant or award Director acquired 90,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Vice President bought 5,000 shares at an average $2.04 ($10,199)
- 4 Open-market sale Chief Executive Officer sold 315,000 shares at an average $2.09 ($658,277)
Page 13 of 16 · 317 filings